Foundry Partners’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-24,117
Closed -$1.64M 402
2021
Q1
$1.64M Sell
24,117
-812
-3% -$63.8K 0.05% 307
2020
Q4
$1.74M Sell
24,929
-151
-0.6% -$9.39K 0.07% 299
2020
Q3
$1.29M Sell
25,080
-355
-1% -$19.5K 0.06% 297
2020
Q2
$1.49M Sell
25,435
-967
-4% -$53.5K 0.07% 272
2020
Q1
$1.34M Hold
26,402
0.08% 273
2019
Q4
$1.96M Sell
26,402
-647
-2% -$40.4K 0.07% 270
2019
Q3
$1.55M Sell
27,049
-63
-0.2% -$4.18K 0.06% 283
2019
Q2
$1.77M Sell
27,112
-84
-0.3% -$5.85K 0.07% 274
2019
Q1
$2.01M Sell
27,196
-1,868
-6% -$131K 0.08% 267
2018
Q4
$1.73M Sell
29,064
-49
-0.2% -$3.95K 0.08% 284
2018
Q3
$2.75M Sell
29,113
-45
-0.2% -$3.88K 0.1% 255
2018
Q2
$2.19M Sell
29,158
-1,908
-6% -$137K 0.09% 269
2018
Q1
$1.88M Sell
31,066
-81
-0.3% -$4.38K 0.08% 285
2017
Q4
$1.45M Sell
31,147
-45,582
-59% -$2.26M 0.06% 294
2017
Q3
$3.88M Sell
76,729
-224
-0.3% -$10.4K 0.16% 233
2017
Q2
$3.83M Sell
76,953
-1,770
-2% -$82.8K 0.16% 225
2017
Q1
$3.34M Sell
78,723
-324
-0.4% -$14.3K 0.14% 253
2016
Q4
$3.2M Buy
+79,047
New +$3.06M 0.14% 249

Other funds holding HQY

Foundry Partners's HQY Position: Q2 2021 in Review

Foundry Partners sold out of HealthEquity (HQY) in Q2 2021, closing a stake of 24,117 shares — an estimated $1.64M sold.

Foundry Partners first reported a position in HQY in Q4 2016 and held it in 18 quarters. The position peaked at $3.88M in Q3 2017. 286 funds tracked by Wall St. Rank hold HQY as of Q2 2021.

  • Foundry Partners reported no remaining HealthEquity position as of Q2 2021 after selling out during the quarter.
  • Foundry Partners sold 24,117 HealthEquity shares in Q2 2021, an estimated $1.64M.
  • Foundry Partners first reported a position in HealthEquity in Q4 2016 and held it in 18 quarters.
  • Foundry Partners's HealthEquity position peaked at $3.88M in Q3 2017.
  • 286 funds tracked by Wall St. Rank held HealthEquity as of Q2 2021.

Based on Foundry Partners's 13F filing for Q2 2021, filed 23 Jul 2021.